Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine

BACKGROUND: MicroRNA-29c (miR-29c) is abnormally expressed in several cancers and serves as an important predictor of tumor prognosis. Herein, we investigate the effects of abnormal miR-29c expression and analyze its clinical significance in acute myeloid leukemia (AML) patients. In addition, decita...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Li-juan, Sun, Guo-kang, Zhang, Ting-juan, Wu, De-hong, Zhou, Jing-dong, Ma, Bei-bei, Xu, Zi-jun, Wen, Xiang-mei, Chen, Qin, Yao, Dong-ming, Qian, Jun, Ma, Ji-chun, Lin, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617691/
https://www.ncbi.nlm.nih.gov/pubmed/31333331
http://dx.doi.org/10.1186/s12935-019-0894-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617691/
https://www.ncbi.nlm.nih.gov/pubmed/31333331
http://dx.doi.org/10.1186/s12935-019-0894-y

Ejemplares similares